ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors
ANI Pharmaceuticals appointed Henry Gosebruch to its Board of Directors effective August 19, 2026, bringing over 30 years of biopharmaceutical strategy and M&A experience. Gosebruch previously served as CEO of Lakefront Biotherapeutics and held strategy leadership roles at AbbVie and J.P. Morgan, where he oversaw more than 100 transactions.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.